It is our heartiest welcome you to the “3^rd International conference on Parkinson's Disease and Movement Disorders” during September 25-26, 2017 at Chicago, USA.

Parkinson’s 2017 is the leading gathering of neurologists, psychiatry, psychology researchers, and neurosurgeons with the theme of Research Strategies, propelled advancements and developments in Parkinson’s disease. Its main aim to deliver ideas for exchange of ideas and thoughts with the leading scientists which covers entire area of neurological disorder.

The live format of the conference will be accredited with CME and CPD Credits.

The objective of this session is to comprehend the inducement, Genesis and Diagnosis and prognosis including care giving of Parkinson’s disease and further hastening the revivification of Parkinson Disease.

Track 1:  Epidemiology of Parkinsons Disease

Parkinsons disease is one of the well-known age related neurodegenerative disorder, second in recurrence just to Alzheimer's disease. Parkinsons disease also causes extensive injury of the motor or sensory pathways extending beyond the pigmental brain stem nuclei. Although the disease symptoms can be controlled by Levodopa but the etiology of the Parkinsons disease remains obscure. In the United States half a million of people are diagnosed as having PD and it is predicted to be triple over next 50 years. PD appears to be slightly more in men than in women usually ranging from 1.2:1 ratio upto 1.5:1. The Parkinsons disease market in US is expected to grow at a rate of 7.3% from sales of of $1.1 billion in 2012 to $2.3 billion in 2022. The population with Parkinsons disease incurred medical expenses of approximately $14.4 per year in United States. In U.S. 15% of people with PD were in the nursing homes as compared to 9 % are of all residents aged 75-84.

Related Conferences Parkinsons Conference| Neurology Congress | Parkinsons Disease Conference| Neurology Conference | Neurologists Conference

6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017, at Amsterdam, Netherlands,  3^rd International Conference Neurological disorders  and Brain Injury during April 18-19, 2017 at London, UK,  2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 8^th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 10^th Annual Canadian Neuroscience Meeting during May 29-June , 7^th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons

UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, Parkinson Society Canada, National Parkinsons Foundation, European Parkinsons Disease Association

 

Track 2:  Neurocognitive Disorders

Neurocognitive disorder is a reduction of cognitive function in one of these areas, especially when physical changes can be seen to have occurred in the cerebrum, for example, after neurological disease, brain injury or drug use. It occurs due to PD with behaviour disturbance. According to the recent projects of the United Nations between 2000 to 2050 the people over 65 years of age will exceed 1.1 billion worldwide. For estimation by 2050 Parkinsons disease will be $285 billion in the USA.

Related Conferences Parkinsons Conference| Neurology Congress| Parkinsons Disease Conference|  Neurology Conference | Neurologists Conference

7^th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,   2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 3^rd International Conference on  Neurological disorders and Brain Injury during April 18-19, 2017 at London, UK , 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  8^th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA.

Associations on Parkinsons 

European Parkinsons Disease Association,   National Parkinsons Foundation,   Parkinson Society Canada,  European Neurological Society,  Movement Disorders Society,  UK Parkinsons Action Network,   American Academy of Neurology

 

Track 3:  Neuromuscular Disorders: Neuromuscular disorder is a disease that affects the peripheral nervous system which includes muscles, nerve-muscle junction, and peripheral nerves in the limbs and motor nerve cells in the spinal cord. Approximately 5600 people in the US are diagnosed with ALS each year. In US each year 750,000 people experience stroke, 11000 people suffer spinal cord injury, 500,000 people suffering from cerebral palsy, 270,000 with multiple sclerosis and 5.3 million with the after affects of a traumatic brain injury and amyotrophic lateral sclerosis.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference  | Neurologists Conference

1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 7^th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA,  8^th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 2^nd   3^rd International Conference on  Neurological disorders and Brain Injury during April 18-19, 2017 at London, UK,  2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA. 

Associations on Parkinsons

American Academy of Neurology,  UK Parkinsons Action Network,   Movement Disorders Society, European Neurological Society,   Parkinson Society Canada,  National Parkinsons Foundation,  European Parkinsons Disease Association

 

Track 4: Risk Factors of Parkinsons disease: Risk factor for the Parkinsons disease mainly depends on age, hereditary, sex and exposure to toxins. Men are more affected than women; 25%-45% are caused by the loss of dopamine which causes rigid movements. Advancing age is a factor that is more consistently associated with an increase in the Parkinsons disease; only 5%-10% of people get PD before age of 40. It involve some of the symptoms like anxiety, cognitive problems, tremor or shaking, depression, trouble sleeping, low voice, loss of smell etc. Now a day’s Head injury and Gene variation is also a factor for Parkinsons disease.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference  | Neurologists Conference

8^th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy,  14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA,  2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  3^rd International Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK,  6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,  1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 7^th Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria.

Associations on Parkinsons

UK Parkinsons Action Network, Movement Disorders Society, , European Neurological Society, Parkinson Society Canada, European Parkinsons Disease Association, National Parkinsons Foundation, American Academy of Neurology

 

Track 5:  Diagnostic and Neuroimaging for Parkinsons Disease: There is no direct treatment for Parkinsons disease as well any blood test or brain scan that confirms the diagnosis. Most PD treatments aim to restore the proper of the neurotransmitter acetylcholine and dopamine by increasing the dopamine levels. Treatment is totally based on the medical history and a neurological examination. At present there is no cure for PD, medications can lessen its symptoms and later stages surgery can be done. Parkinsons in the body; magnetic resonance imaging (MRI) is a test that produces very clear iamge of the human body without the use of X-rays. Instead of MRI uses a large magnet, radio waves, and a computer to produce these images. Medications are in three stages- first includes the drug which is known as levodopa which increase the dopamine in the brain, the second set of drugs eases some of the Parkinsons disease symptoms and the third set of drugs helps to control the non-motor symptoms including depression.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference |  Neurologists Conference

13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,   3^rdInternational Conference on Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK,    2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany,  14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA,  8^th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 7^th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons

National Parkinsons Foundation,  UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society,  European Neurological Society, Parkinson Society Canada, European Parkinsons Disease Association

 

Track 6:  Pathophysiology and pharmacology: The most prominent pathological lesion observed in PD occurs in the basal ganglia of the brain’s extra-pyramidal system. Non-PD patients and without nigrostriatal degeneration develope dyskinesias in response to dopaminergic. It is caused by gradual loss of nerve cells in the brain area called nigra and also by low and falling dopamine levels. The worldwide prevalence of Parkinson disease is anticipated to grow to 2.89 million cases worldwide by 2022.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 7^th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  3^rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 8^th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy,  14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria.

Associations on Parkinsons  European Parkinsons Disease Association, National Parkinsons Foundation,   UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society,  European Neurological Society,  Parkinson Society Canada

 

Track 7:  Parkinsons disease: Complications: Parkinsons disease is not thought to be a life threatening condition, but rather it has a vast effect of your personal satisfaction. With time, the sickness can bring about issues with speech, movement disorder, and brain functioning. The major complication in Parkinsons disease are blood pressure changes, depression, emotional changes, thinking difficulties, fatigue, sexual dysfunction, smell dysfunction, pain and sleep disorders.

Related Conference Parkinsons Conference | Neurology Congress |  Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 3^rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK,    2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA,  8^th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 7^th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons  Parkinson Society Canada, European Neurological Society, Movement Disorders Society, American Academy of Neurology,   UK Parkinsons Action Network, National Parkinsons Foundation,  European Parkinsons Disease Association

 

Track 8:  Managing life with Parkinsons disease: It is important to develope a solid PD management plan because PD is a chronic disease. Managing with Parkinsons disease includes building a health care team with proper doctors, proper intake of medications, exercises, nutrition and sleep.

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference | Neurology Conference  | Neurologists Conference

7^th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy ,8^th International Conference on Alzheimer’s Disease and Dementia  during October 16- 18, 2017 at Rome, Italy,  6^th International Conference on Vascular Dementia  during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,   3^rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA, 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria.

Associations on Parkinsons European Neurological Society,   Parkinson Society Canada, European Parkinsons Disease Association, National Parkinsons Foundation, Movement Disorders Society,  American Academy of Neurology, UK Parkinsons Action Network

 

Track 9:  Novel Insights and therapeutics for Parkinsons disease: Parkinsons disease is the essential growth driver of the worldwide Parkinsons disease therapeutics. Most mutations such as SNCA, PINK1, PARK2, PARK7, PLA2G6, FBXO7 and ATP13A2 are the rare cause of the disease and one particular mutation in LRRK2 has been found common in certain populations. The enzymatic function of the mitochondrial localized kinase PINK1 is thereby essential and delivers a fast production of Parkin from its uniform distribution in the cytoplasm to damaged mitochondria. The therapeutics of Parkinsons Disease includes designing a Clinical trial for Parkinson, Outcome of clinical trials in PSP, therapeutic options for mood, Cognition and Psychosis. Physical therapy cannot cure Parkinsons disease but therapy can help to compensate the changes brought about by the condition, physical therapy can help with balance problems, fatigue, pain, weakness and sometimes local heat application is produced with high frequency to relieve muscle aches and pain.

Related Conference Parkinsons Conference| Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA ,13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria , 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA, 8^th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands,   3^rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 7^th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons UK Parkinsons Action Network, American Academy of Neurology, Movement Disorders Society, European Neurological Society, European Parkinsons Disease Association, National Parkinsons Foundation,    Parkinson Society Canada

 

Track 10:  Neural Transplantation: Neural transplantation is the transplantation of nerve cells and tissues into the brain and spinal cord. The cell replacement for Parkinsons Disease is based on two hypothesis- firstly the early symptoms of PD are dependent on the loss of the dopaminergic neurons in the nigrostriatal pathways and secondly the dopaminergic neurons and gathered into dopamine deficient striatum can replace those neurons which has been lost during the disease process and can reverse some extent of the major symptoms of Parkinson disease.

Related Conference Parkinsons Conference| Neurology Congress | Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

7^th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  8^th International Conference on Alzheimer’s Disease and Dementia during October 16- 18, 2017 at Rome, Italy, 3^rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 6^th International Conference on Vascular Dementia  during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany,  14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria,  1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA.   

Associations on Parkinsons  Parkinson Society Canada, UK Parkinsons Action Network, National Parkinsons Foundation,  European Parkinsons Disease Association, European Neurological Society, American Academy of Neurology, Movement Disorders Society

 

Track 11:  Gene Therapy: It is a technique which aims at treating diseases by genetically modifying population of cells into the patient body instead of using drugs and surgery to prevent from any disorder. Various methods have been developed for the gene delivery to the target cells which includes viral and non-viral systems. It is a creation of producing new cells that will produce a specific neurotransmitter which is dopamine to protect the neural system and then these cells are transplanted to the patient having Parkinsons disease because the neurons cannot be renewed further. Some important reasons are there for focusing gene therapy which includes firstly there is no cure for PD disease; secondly some genes which are identified can modulate the neuron phenotype.

Related Conference Parkinsons Conference |Neurology Congress |Parkinsons Disease Conference | Neurology Conference | Neurologists Conference

1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA , 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  3^rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK,  8^th International Conference on Alzheimer’s Disease and Dementia  during October 16- 18, 2017 at Rome, Italy, 6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 7^th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy.

Associations on Parkinsons

Movement Disorders Society, Parkinson Society Canada, American Academy of Neurology, European Neurological Society, UK Parkinsons Action Network,  National Parkinsons Foundation, European Parkinsons Disease Association

 

Track 12:  Paediatric Movement disorders: Paediatric movement disorder is a moderately new and developing field of child neurology. While hypokinetic scatters, for example, Parkinson disease prevails in adults. There are many genetic disease which cause secondary movement disorders in childhood. Propels in paediatric movement disorder have been made by solidifying movement disorder definitions, growing the range of clinical phenotypes, understanding genetic reasons for movement disorders, and thoroughly assessing treatment adequacy for normal movement disorders. The central nervous systems typically implicated in disorders of movement are the basal and frontal cortex. Five areas were highlighted these advances: consensus definitions, newly found PRRT2 mutation, clinical and genetic range of GLUT-1 lack and neurodegeneration with brain iron aggregation (NBIA) issue, and exhaustive behavioural interventions for tics (CBIT).

Related Conference Parkinsons Conference | Neurology Congress | Parkinsons Disease Conference  |Neurology Conference  | Neurologists Conference

2^nd International Conference and Exhibition on Dual Diagnosis during May 15-16, 2017 at Munich, Germany, 14^th Global Neuroscience Conference during July 17-19, 2017 at Chicago, USA, 14^th World Congress on Neurology and Neurological Disorders during July 17-19, 2017 at Chicago, USA,  8^th International Conference on Alzheimer’s Disease and Dementia  during October 16- 18, 2017 at Rome, Italy, 3^rdInternational Conference on  Neurological disorders and Brain Injury during April 17-28, 2017 at London, UK, 6^th International Conference on Vascular Dementia during Feb 27-Mar 01, 2017 at Amsterdam, Netherlands, 7^th  Global Experts Meeting on Neuropharmacology during July 31-August 02, 2017 at Milan, Italy, 13^th International Conference on Alzheimer’s and Parkinson’s Disease during March 29- April 2, 2017 at Vienna Austria, 1^st Pan American Parkinson’s Disease and Movement Disorders Congress during February 24-26, 2017 at Miami, FL, USA.

Associations on Parkinsons  European Parkinsons Disease Association, Movement Disorders Society, National Parkinsons Foundation, Parkinson Society Canada, American Academy of Neurology, European Neurological Society, UK Parkinsons Action Network